BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36859309)

  • 1. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
    Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
    Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
    Baumann BC; Bernstein KA; DeLaney TF; Simone CB; Kolker JD; Choy E; Levin WP; Weber KL; Muniappan A; Berman AT; Staddon A; Hartner L; Van Tine B; Hirbe A; Glatstein E; Hahn SM; Nagda SN; Chen YL
    J Surg Oncol; 2020 Oct; 122(5):877-883. PubMed ID: 32588468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases.
    Asha W; Koro S; Mayo Z; Yang K; Halima A; Scott J; Scarborough J; Campbell SR; Budd GT; Shepard D; Stephans K; Videtic GM; Shah C
    Am J Clin Oncol; 2023 Jun; 46(6):263-270. PubMed ID: 36914598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
    Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
    BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Control Outcomes Using Stereotactic Body Radiation Therapy or Surgical Resection for Metastatic Sarcoma.
    Gutkin PM; von Eyben R; Chin A; Donaldson SS; Oh J; Jiang A; Ganjoo KN; Avedian RS; Bruzoni M; Steffner RJ; Moding EJ; Hiniker SM
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):771-779. PubMed ID: 35643255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for distant metastases to the head and neck.
    Mutsaers A; Abugharib A; Poon I; Loblaw J; Bayley A; Zhang L; Chin L; Galapin M; Erler D; Sahgal A; Higgins K; Enepekides D; Eskander A; Karam I
    Support Care Cancer; 2024 Mar; 32(4):230. PubMed ID: 38488881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
    Navarria P; Baldaccini D; Clerici E; Marini B; Cozzi L; Franceschini D; Bertuzzi AF; Quagliuolo V; Torri V; Colombo P; Franzese C; Bellu L; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):762-770. PubMed ID: 35987453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
    Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine.
    Kim E; Kim MS; Paik EK; Chang UK; Kong CB
    Radiat Oncol; 2023 Sep; 18(1):156. PubMed ID: 37736735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
    Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
    Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
    Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.
    Baumann BC; Nagda SN; Kolker JD; Levin WP; Weber KL; Berman AT; Staddon A; Hartner L; Hahn SM; Glatstein E; Simone CB
    J Surg Oncol; 2016 Jul; 114(1):65-9. PubMed ID: 27111504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for sarcoma pulmonary metastases.
    Lebow ES; Lobaugh SM; Zhang Z; Dickson MA; Rosenbaum E; D'Angelo SP; Nacev BA; Shepherd AF; Shaverdian N; Wolden S; Wu AJ; Gelblum DY; Simone CB; Gomez DR; Alektiar K; Tap WD; Rimner A
    Radiother Oncol; 2023 Oct; 187():109824. PubMed ID: 37532104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study.
    Lee TH; Kim HJ; Kim JH; Kim MS; Jang WI; Kim E; Kim KS
    Radiat Oncol; 2023 Apr; 18(1):68. PubMed ID: 37061679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.